1 / 1

Exclusion criteria (67) Patient cohort <100 (50) Re-analysis of same cohort (5) Off topic (12)

Studies on genetic polymorphisms in Hodgkin N=112. Exclusion criteria (67) Patient cohort <100 (50) Re-analysis of same cohort (5) Off topic (12). Unique studies selected for review N=45. Secondary malignancies/ toxicities N=3**. HLA susceptibility N=11. Non-HLA susceptibility N=19.

azuka
Download Presentation

Exclusion criteria (67) Patient cohort <100 (50) Re-analysis of same cohort (5) Off topic (12)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Studies on genetic polymorphisms in Hodgkin N=112 Exclusion criteria (67) Patient cohort <100 (50) Re-analysis of same cohort (5) Off topic (12) Unique studies selected for review N=45 Secondary malignancies/ toxicities N=3** HLA susceptibility N=11 Non-HLA susceptibility N=19 Prognosis N=15* GWAS N=5 *7 studies shared between non-HLA susceptibility and prognosis **1 study shared between prognosis and secondary malignancies/toxicities Supplementaryfigure 1.

More Related